<DOC>
	<DOCNO>NCT02487108</DOCNO>
	<brief_summary>The primary objective study evaluate analgesic efficacy hydrocodone bitartrate/acetaminophen immediate-release tablet dose 5.0 mg/325 mg , 7.5 mg/325 mg , 10 mg/325 mg every 4 6 hour compare placebo treat patient moderate severe pain follow bunionectomy</brief_summary>
	<brief_title>Study Evaluate Analgesic Efficacy Safety Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets Patients With Moderate Severe Pain Following Bunionectomy</brief_title>
	<detailed_description />
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>1 . Men woman age 18 75 year , inclusive . 2 . Patients schedule undergo primary unilateral first metatarsal Austin bunionectomy distal osteotomy internal fixation without collateral procedure ( ie , uncomplicated procedure ) . 3 . Patients accord American Society Anesthesiologists Physical Status ( PS ) classification system classify PS1 ( normal , healthy patient ) PS2 ( mild systemic disease ) . 4 . The patient able speak English willing provide write informed consent , include write opioid agreement , participate study . 5 . The patient body mass index ( BMI ) 18.0 33.0 kg/m2 ( inclusive ) time screen . 6 . The patient generally good health determine medical history , medical examination , ECG , serum chemistry , hematology , urinalysis , serology . 7 . Women childbearing potential ( surgically sterile 2 year postmenopausal ) must use medically acceptable method contraception must agree continue use method duration study 30 day discontinuation study drug , unless exclusively samesex partner . Acceptable method contraception include intrauterine device ( IUD ) know failure rate le 1 % per year , hormonal contraceptive ( oral , implanted , transdermal , inject ) , barrier method spermicide , abstinence , partner vasectomy . NOTE : A woman consider surgically sterile tubal ligation , hysterectomy , bilateral salpingooophorectomy bilateral oophorectomy , hysterectomy bilateral salpingooophorectomy . 8 . The patient , man , surgically sterile , , capable produce offspring , currently use medically acceptable method contraception agree continue use method duration study ( 90 day take last dose study drug possible effect spermatogenesis ) , unless exclusively samesex partner . Acceptable method contraception include abstinence , barrier method spermicide , female partner 's use steroidal hormonal contraceptive ( oral , implanted , transdermal , inject ) conjunction barrier method , female partner 's use IUD know failure rate le 1 % per year , female partner surgically sterile 2 year postmenopausal . In addition , male patient may donate sperm duration study 90 day take study drug . 9 . The patient must willing able comply study restriction remain clinic require duration study , willing return clinic followup evaluation specify protocol . 10 . The patient must participate study involve investigational agent enrol present study . 11 . The patient must report pain intensity score â‰¥4 11point NPRS11 within 9 hour stop postsurgical analgesia immediately randomization . 12 . The patient free surgical anesthetic complication surgery , perform use intraoperative anesthetic regimen postoperative analgesic regimen follow appropriately without deviation would confound analgesic assessment receipt investigational product . 1 . The patient chronic pain condition , exclude bunion pain require take opioid analgesic within 30 day prior surgery use nonopioid analgesic ( acetylsalicylic acid , acetaminophen , nonsteroidal antiinflammatory drug ) within 24 hour prior surgery . Stable therapy &gt; 30 day acetylsalicylic acid ( 81 mg/day ) allow cardiovascular prophylaxis . 2 . Use glucocorticoid ( except nasal corticosteroid spray and/or topical corticosteroid ) condition within 6 month study drug administration . 3 . The patient us nonpharmacologic pain management technique ( eg , physical technique , physiotherapy , massage therapy , acupuncture , biofeedback , and/or psychological support ) unable unwilling discontinue prior randomization ( study start ) . 4 . The patient medical psychiatric condition receive concomitant medication/therapy would , opinion investigator , compromise patient 's safety , compliance study protocol procedure , collection data . 5 . The patient clinically significant abnormality physical examination and/or clinical laboratory test value . 6 . The patient pregnant lactate woman . ( Any woman become pregnant study withdrawn study . ) 7 . The patient use investigational drug within 1 month screen visit . 8 . The patient participate currently ongoing research study . 9 . The patient disorder may interfere gastrointestinal ( GI ) drug absorption ( eg , gastric bypass surgery , lap band , malabsorption syndrome , inflammatory bowel disease ) condition may effect patient safety efficacy aspects participation opinion investigator . 10 . The patient allergic serious reaction hydrocodone opioids , acetaminophen , ropivacaine , lidocaine , ketorolac , ibuprofen , propofol , drug require study protocol . 11 . The patient recent history ( within 5 year ) current evidence alcohol substance abuse , exception nicotine . 12 . The patient positive urine drug screen ( UDS ) cocaine , marijuana , opioids , amphetamine , methamphetamine , benzodiazepine , barbiturate , and/or methadone , unless explain use prescription medication . 13 . The patient history suicidality assess patient medical history and/or CSSRS . 14 . The patient expect elective surgery study bunionectomy . 15 . The patient history malignancy within 5 year ( except treat basal cell carcinoma ) . 16 . The patient positive test result hepatitis B surface antigen antibody hepatitis C , know test positive human immunodeficiency virus . 17 . The patient receive monoamine oxidase inhibitor ( MAOI ) within 14 day first dose study drug . 18 . The investigator believe patient suitable study reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>